Histopathologic effects of mitomycin-C on endoscopic transnasal dacryocystorhinostomy


Ugurbas S., Zilelioglu G., Sargon M., Anadolu Y., Akiner M., Akturk T.

OPHTHALMIC SURGERY AND LASERS, cilt.28, sa.4, ss.300-304, 1997 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 28 Sayı: 4
  • Basım Tarihi: 1997
  • Dergi Adı: OPHTHALMIC SURGERY AND LASERS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.300-304
  • Ankara Üniversitesi Adresli: Evet

Özet

BACKGROUND AND OBJECTIVES: The antimetabolite mitomycin-C is now being used in endoscopic transnasal dacryocystorhinostomies to prevent the closure of osteotomies. PATIENTS AND METHODS: A 0.5-mg/ml solution of mitomycin-C was applied to the osteotomy site for 21/2 minutes intraoperatively. Specimens from four patients were collected during surgery and at 15 days, 1 month, 3 months, and 6 months after surgery. The specimens were examined under light and electron transmission microscopy and were compared with control specimens. RESULTS: Light microscopy showed attenuated epithelium with Subepithelial connective hypocellular. Electron microscopy confirmed these findings and demonstrated swelling of mitochondria, dilatation of endoplasmic reticulum, and chromatin-dense granules in nuclei of fibroblasts. CONCLUSION: By causing a decrease in density and cellularity of mucosa, topical use of mitomycin-C may enhance the success of surgery; however, further studies are necessary to determine the ultimate potential of this agent for this procedure.